This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A two part protocol to assess, using double blind ...
Clinical trial

A two part protocol to assess, using double blind placebo control, the safety, tolerability, and pharmacokinetics of ascending single doses of a new intra-articular administration formulation of SAR113945 (IKK inhibitor) followed by assessment of efficacy

Read time: 1 mins
Last updated:29th Sep 2011
Part 1 TDU11685: assess safety in patients with knee osteoarthritis. Part 2 ACT12505: assess efficacy in patients with knee osteoarthritis
Category Value
Study start date 2011-09-29

View full details